1,4-butanediol has been researched along with Chemical Dependence in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, KM; Goodwin, AK; Weerts, EM | 1 |
| Brunt, TM; van Amsterdam, JG; van den Brink, W | 1 |
| Claridge, H; Corazza, O; Corkery, JM; Elliott, S; Goodair, C; Loi, B; Schifano, F | 1 |
| Brown, PR; Gibson, KM; Goodwin, AK; Jakobs, C; Jansen, EE; Weerts, EM | 1 |
| Duketis, E; Holtmann, M; Maier, J; Poustka, F; Radeloff, D; Schirman, S; Wagner, A; Wöckel, L; Zepf, FD | 1 |
| Mitcheson, L; Winstock, AR | 1 |
| Dematteis, M; Mallaret, M; Pennel, L | 1 |
| Palmer, RB | 1 |
| Atzeri, S; Carai, MA; Colombo, G; Gessa, GL; Lobina, C; Maccioni, P; Maher, TJ; Orrù, A; Quang, LS | 1 |
| Gibson, KM; Snead, OC | 1 |
| Ashraf, T; Clarke, S; Dargan, PI; Greene, SL; Holt, DW; Ramsey, J; Shather, Z; Trivedy, C; Warren-Gash, C; Wood, DM | 1 |
| Greter, J; Knudsen, K; Verdicchio, M | 1 |
| Quang, LS; Shannon, M | 1 |
| Hall, BJ; McCutcheon, JR; Peacock, EA; Smith, SW; Spillane, J; Zvosec, DL | 1 |
| Baud, FJ; Fompeydie, D; Garnier, R; Mégarbane, B | 1 |
8 review(s) available for 1,4-butanediol and Chemical Dependence
| Article | Year |
|---|---|
GHB, GBL and 1,4-BD addiction.
Topics: 4-Butyrolactone; Animals; Butylene Glycols; Humans; Hydroxybutyrates; Substance-Related Disorders | 2014 |
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
Topics: 4-Butyrolactone; Butylene Glycols; Female; Humans; Male; Sodium Oxybate; Substance-Related Disorders; United Kingdom | 2015 |
[Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Topics: 4-Butyrolactone; Acute Disease; Adolescent; Anesthetics, Intravenous; Antipsychotic Agents; Benzodiazepines; Butylene Glycols; Child; Critical Care; Delusions; Diagnosis, Differential; Drug Interactions; Humans; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
New recreational drugs and the primary care approach to patients who use them.
Topics: Alkaloids; Anesthetics, Dissociative; Anesthetics, Intravenous; Butylene Glycols; Central Nervous System Stimulants; Humans; Illicit Drugs; Ketamine; Primary Health Care; Referral and Consultation; Sodium Oxybate; Substance-Related Disorders | 2012 |
[Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)].
Topics: 4-Butyrolactone; Butylene Glycols; Humans; Hydroxybutyrates; Illicit Drugs; Knowledge; Models, Biological; Substance-Related Disorders | 2012 |
Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
Topics: 4-Butyrolactone; Body Temperature Regulation; Butylene Glycols; GABA Modulators; Humans; Illicit Drugs; Seizures; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2004 |
Gamma-hydroxybutyric acid.
Topics: 4-Butyrolactone; Animals; Butylene Glycols; Humans; Hydroxybutyrates; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.
Topics: 4-Butyrolactone; Adjuvants, Anesthesia; Adolescent; Butylene Glycols; Emergency Medical Services; Female; Humans; Lorazepam; Seizures; Sodium Oxybate; Structure-Activity Relationship; Substance-Related Disorders; Treatment Outcome | 2000 |
7 other study(ies) available for 1,4-butanediol and Chemical Dependence
| Article | Year |
|---|---|
Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.
Topics: Animals; Butylene Glycols; Conditioning, Operant; Infusions, Parenteral; Male; Papio anubis; Prodrugs; Severity of Illness Index; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2013 |
Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Topics: 4-Butyrolactone; Animals; Area Under Curve; Behavior, Animal; Butylene Glycols; Conditioning, Operant; Dose-Response Relationship, Drug; Food; GABA Modulators; Male; Motor Skills; Papio; Prodrugs; Reward; Sodium Oxybate; Substance-Related Disorders | 2009 |
Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
Topics: Animals; Butylene Glycols; Disease Models, Animal; GABA-B Receptor Antagonists; Hydroxybutyrates; Male; Morpholines; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Topics: 4-Butyrolactone; Adult; Aged; Butylene Glycols; Emergency Medical Services; Female; Humans; Illicit Drugs; Length of Stay; Male; Middle Aged; Retrospective Studies; Sodium Oxybate; Substance-Related Disorders | 2008 |
High mortality rates among GHB abusers in Western Sweden.
Topics: 4-Butyrolactone; Adolescent; Adult; Anesthetics, Intravenous; Butylene Glycols; Cause of Death; Female; Forensic Medicine; Humans; Illicit Drugs; Male; Police; Sodium Oxybate; Substance Abuse Detection; Substance-Related Disorders; Sweden | 2008 |
Adverse events, including death, associated with the use of 1,4-butanediol.
Topics: Adult; Butylene Glycols; Dietary Supplements; Fatal Outcome; Female; Humans; Male; Psychomotor Agitation; Pulmonary Edema; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders; Unconsciousness; Vomiting | 2001 |
Treatment of a 1,4-butanediol poisoning with fomepizole.
Topics: Adult; Antidotes; Butylene Glycols; Coma; Fomepizole; Humans; Hydroxybutyrates; Infusions, Intravenous; Male; Pyrazoles; Seizures; Solvents; Substance-Related Disorders; Treatment Outcome | 2002 |